INTROUDCTION
Electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), and deep brain stimulation (DBS) are
increasingly being used for a wide range of CNS disorders. Each device is under investigation for the potential treatment for a wide range of CNS
disorders. This Market Brief provides an insight into the commercial opportunities available to these devices.
SCOPE OF THE REPORT
- Overview of ECT, VNS, TMS and DBS, the theories for mechanism of action and current therapeutic uses
- Analysis of current trial data and the therapeutic potential of each device and
- Insight into how each manufacturer can position their product against its competitors
REPORT HIGHLIGHTS
TMS and Cyberonics' VNS are both being positioned as treatments for depression, but proving to the regulatory authorities and physicians that they
are more efficacious than ECT will prove difficult
DBS has been shown to be truly effective in treating Parkinson's disease but with numerous
companies having drugs in development, this could potentially reduce the number of patients needing DBS. Therefore, DBS manufacturers should focus on
niche sectors of the market
KEY REASONS TO BUY THIS REPORT
- Which medical devices are used to treat CNS disorders, what are their mechanisms of action, and current indications?
- What is the therapeutic potential of each device? How can each manufacturer position their products against its competitors?
- Are VNS and TMS likely to have an impact on ECT? What does the future for DBS hold?
View Cart
